Richard Beckman

Company: Adverum

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Discussing the Immunogenicity of the Eye 12:00 pm

Discussing the implications of treatments delivery to the immuno-privileged eye What are the most common causes of inflammation? How do we overcome ocular inflammation – is it possible?Read more

day: Day Two Track A - Morning

Showcasing ADVM-022 as a Treatment for Neovascular AMD 9:30 am

Wet AMD: the rationale for using gene therapy for treatment Utilizing aAV.7m8 vector for intravitreal administration and preclinical and clinical support for dosing Clinical experience with ADVM-022 in Wet AMDRead more

day: Day Two